These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 18375000

  • 1. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N, Diévart F, Thébaut JF, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Int J Cardiol; 2009 Mar 20; 133(1):32-40. PubMed ID: 18375000
    [Abstract] [Full Text] [Related]

  • 2. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 20; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 3. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec 20; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 20; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 10. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators.
    Crit Pathw Cardiol; 2009 Sep 20; 8(3):104-11. PubMed ID: 19726929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 17. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
    Pelc-Nowicka A, Bryniarski L, Mirek-Bryniarska E, Zabojszcz M.
    Kardiol Pol; 2009 Dec 21; 67(12):1335-41. PubMed ID: 20054764
    [Abstract] [Full Text] [Related]

  • 18. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY, Chen AY, Peterson ED, Becker RC, Gibler WB, Ohman EM, Roe MT.
    Eur Heart J; 2008 May 21; 29(9):1103-9. PubMed ID: 18353757
    [Abstract] [Full Text] [Related]

  • 19. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 20. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 23; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.